(Reuters) -The U.S. Centers for Disease Control and Prevention is still recommending COVID-19 vaccines for healthy children, ...

Pfizer Inc. (NYSE: PFE) today announced statistically significant and clinically meaningful survival results from the Phase 3 ...

First-line treatment with the triplet combination of encorafenib, cetuximab and mFOLFOX6 significantly improved survival ...

A new drug combination has been shown to double survival time for patients with a particularly aggressive type of colorectal ...

There have been important recent advances in the management of Crohn's disease, including new classes of biological or small molecule therapies, an appreciation that endoscopic mucosal healing results ...

The Centers for Disease Control and Prevention says children without underlying health conditions "may receive" a COVID-19 ...

The U.S. Centers for Disease Control and Prevention is still recommending COVID-19 vaccines for healthy children, according ...

The BREAKWATER study enrolled patients with newly diagnosed colon cancer that harbors a mutation called BRAF 600E that makes ...

Pfizer CEO Dr. Albert Bourla speaks to CNN’s Meg Tirrell about pushing past vaccine skepticism to work with the Trump ...

The U.S. Centers for Disease Control and Prevention is still recommending COVID-19 vaccines for healthy children, according ...

Pharmaceutical rivals don’t often come to each other’s defense. But after the US Department of Health and Human Services ...

The CDC's latest vaccine guidance includes a bombshell recommendation that defies the Trump administration and health ...